LifePlan Financial Group’s Gilead Sciences GILD Stock Holding History

LifePlan Financial Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$2K	Hold	27	–	–	﹤0.01%	525
2020 Q2	$2K	Hold	27	–	–	﹤0.01%	531
2020 Q1	$2K	Hold	27	–	–	﹤0.01%	505
2019 Q4	$2K	Hold	27	–	–	﹤0.01%	514
2019 Q3	$2K	Hold	27	–	–	﹤0.01%	508
2019 Q2	$2K	Hold	27	–	–	﹤0.01%	508
2019 Q1	$2K	Sell	27 -6	-18%	-$399	﹤0.01%	508
2018 Q4	$2K	Hold	33	–	–	﹤0.01%	500
2018 Q3	$3K	Hold	33	–	–	﹤0.01%	480
2018 Q2	$2K	Hold	33	–	–	﹤0.01%	482
2018 Q1	$2K	Buy	+33	New	+$2.62K	﹤0.01%	468

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

LifePlan Financial Group's GILD Position: Q3 2020 in Review

LifePlan Financial Group held its Gilead Sciences (GILD) position steady in Q3 2020 at 27 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #525.

LifePlan Financial Group first reported a position in GILD in Q1 2018 and has held it in 11 quarters since. The position peaked at $3K in Q3 2018. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

LifePlan Financial Group held 27 shares of Gilead Sciences worth $2K as of Q3 2020.
LifePlan Financial Group left its Gilead Sciences share count unchanged in Q3 2020.
Gilead Sciences made up ﹤0.01% of LifePlan Financial Group's portfolio in Q3 2020, its #525 holding.
LifePlan Financial Group first reported a position in Gilead Sciences in Q1 2018 and has held it in 11 quarters since.
LifePlan Financial Group's Gilead Sciences position peaked at $3K in Q3 2018.
1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on LifePlan Financial Group's 13F filing for Q3 2020, filed 30 Oct 2020.